Are you sure you want to log out?
You can always login again from the home screen

Thank You

Thank you for your feedback

COVID-19

COVID-19

Remdesivir approved for COVID-19 treatment- A review

COVID-19

Is GS-5245- an oral pro-drug of the parent nucleoside of remdesivir, safe for use in healthy people?

COVID-19

Real-world evidence on the effect of Remdesivir on mortality rate in hospitalized COVID-19 patients: Study

COVID-19

How effective and safe is remdesivir in patients hospitalized for COVID-19 with moderately and severely reduced kidney function?

COVID-19

Novel study investigates characteristics of hospitalized immunocompromised COVID-19

COVID-19

Irrespective of strain, COVID-19 patients in ICU treated with remdesivir had reduced readmission risk - Study

COVID-19

In hospitalised COVID-19 patients requiring high-flow oxygen in the US, Remdesivir is associated with reduced mortality

COVID-19

Lower mortality observed in cancer patients hospitalized for COVID-19 put on Remdesivir

COVID-19

Reduction in readmissions observed after Remdesivir treatment in immunocompromised patients hospitalised with COVID-19

COVID-19

Breathlessness found to be most common long COVID symptom in immunocompromised COVID-19 patients

COVID-19

Improvement in biomarkers associated with disease severity discovered in COVID-19 patients treated with Remdesivir

COVID-19

Novel over-the-counter Flu and COVID-19 test approved by the FDA

COVID-19

COVID can rebound back…even without Paxlovid!

COVID-19

Four major sub-types of long COVID identified

COVID-19

Management of COVID related ARDS: What have we learnt during the pandemic?

COVID-19

Scientists create new, more potent antibodies to treat coronavirus variants

COVID-19

A new coronavirus variant BQ.1.1 may surge the infection rate

COVID-19

8 in 10 people deal with brain fogging after long COVID

COVID-19

Omicron infected exhale 1000 times more viral RNA than other variants

COVID-19

Never seen before symptoms of Omicron on the rise

COVID-19

No signs of slowing down! SARS-CoV-2 evolving each day

COVID-19

New Omicron variants stronger than ever

COVID-19

Four new, highly transmissible Omicron variants picking up

COVID-19

Allergic Rhinitis found to be protective against COVID-19

COVID-19

Risk of heart disease persists months after recovery from COVID-19

COVID-19

COVID rebound fiercer after anti-viral treatment

COVID-19

Smoking and COVID-19 : Decoding the link

COVID-19

Incubation period of SARS-CoV-2 variants helps determine isolation period in COVID-19 : Study

COVID-19

The rise of BA.4 and BA.5 Omicron variants

COVID-19

COVID-19 patients with no symptoms are two-thirds less likely to pass the virus to others

COVID-19

Long COVID still a risk, even for vaccinated people

COVID-19

COVID-19 Pandemic vs. Endemic

COVID-19

Long COVID (post-COVID syndrome): Brain fog

COVID-19

COVID-19 vaccine protection among US children and adolescents amid the Omicron variant surge

COVID-19

WHO issues new COVID-19 guidelines, April, 2022

COVID-19

COVID-19 outbreak seeded by Omicron variants in Hong Kong: Superspreading and transmission heterogeneity

COVID-19

Covid-19 severity in diabetes and non-diabetes

COVID-19

SARS-CoV-2 C.1.2: Emergence, phenotypic characterization, vaccine efficacy

COVID-19

Covid-19 management in children

COVID-19

Why therapeutic monoclonal antibodies have limited or no efficacy against SARS-CoV-2 Omicron BA.2 variant?

COVID-19

Antiviral activity assessment of remdesivir and GS-441524 against Delta, Omicron, and other emergent SARS-CoV-2 variants

COVID-19

Do antibody and antiviral treatments still work against COVID 19 omicron BA.2 variant?

COVID-19

Pregnancy outcomes among women with COVID-19 infection

COVID-19

ESCMID Guidelines for treatment of long covid

COVID-19

Long Covid: Persistent Symptoms 12 months after discharge

COVID-19

Characterizing long COVID and its impact

COVID-19

Long COVID attributes and predictors

COVID-19

Management of Non-hospitalized COVID-19 patients

COVID-19

Biological basis and pharmacological treatment strategy for Long COVID

COVID-19

Prevalence of fungal infections in mechanically ventilated patients in COVID-19

COVID-19

SARS-CoV2 variants: Transmissibility, resistance to host immunity and molecular diagnosis

COVID-19

Antiviral therapies and SARS-CoV2-host cell surface interactions

COVID-19

Importance of antivirals in curtailing the pandemic

COVID-19

Health implications of the genetic drift in the genome of SARS COV-2

COVID-19

Is SARS-CoV2 Omicron variant more transmissible?

COVID-19

COVID19 Antivirals : Remdesivir to be active against Omicron variant

COVID-19

Keeping pace with ever-evolving COVID-19 pneumonia

COVID-19

Fresh concerns and unanswered questions about new Omicron variant

COVID-19

Antiviral drugs for the future

COVID-19

Delta variant B.1.617.2 is resistant to antibody neuralization

COVID-19

COVID-19 - A seasonal low - temperature infection?

COVID-19

Challenges in diagnosis and treatment of autonomic complications of COVID-19

COVID-19

Covid-19 protection by pre-existing HCoV antibodies

COVID-19

Fully vaccinated individuals may shed infectious COVID-19 virus

COVID-19

Symptom clusters in COVID-19: A potential clinical prediction tool from the COVID Symptom Study app

COVID-19

Administration of COVID-19 vaccines in immunocompromised patients

COVID-19

Statins linked to lower mortality in Covid-19

COVID-19

Pulmonary Immunothrombosis leading to hypoxia in COVID-19

COVID-19

Aggravating factors of post covid secondary fungal infections

COVID-19

Burden of new SARS-CoV-2 variants in India

Back to top